Portfolio Spotlight

Making it as easy to write DNA as it is to read it

September 2020 - “The results DNA Script has already obtained in making functional DNA today is impressive, but even more inspiring is the company’s vision of a tomorrow with manufacturing platforms focused upon massively parallel synthesis of longer, high-fidelity nucleic acids — a vision that holds great promise for completely transforming the molecular and synthetic biology solutions market while enabling the data-intensive technology of tomorrow,” said Nick Naclerio, founding partner at Illumina Ventures.  

Imagine How Genomics Will Transform Our Future.

Copyright 2020 IIF Management Company LLC.  All rights reserved.  “Illumina” and “Illumina Ventures” are trademarks of Illumina, Inc. and are used herein with their permission.  All other company names, logos, and other trademarks are the property of their respective owners.